Community-acquired pneumonia (CAP) in patients with chronic obstructive pulmonary disease (COPD)

S. Avdeev, G. Baimakanova, P. Zubairova, A. Chuchalin (Moscow, Russian Federation)

Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Session: COPD: exacerbation and clinical problems
Session type: Thematic Poster Session
Number: 3474
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Avdeev, G. Baimakanova, P. Zubairova, A. Chuchalin (Moscow, Russian Federation). Community-acquired pneumonia (CAP) in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 2009; 34: Suppl. 53, 3474

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Community-acquired pneumonia (CAP) in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003

Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Does the condition of chronic obstructive pumonary disease (COPD) have a prognostic benefit in patients with community-acquired pneumonia (CAP)?
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003

Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB)
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006

COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006



Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients
Source: Eur Respir J 2012; 39: 855-861
Year: 2012



Viral infections as a cause of chronic obstructive pulmonary disease (COPD) exacerbations
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009



Mycoplasma pneumoniae infection and acute exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

Infection as a comorbidity of COPD
Source: Eur Respir J 2010; 35: 1209-1215
Year: 2010



Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 518s
Year: 2005

How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients?
Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients
Year: 2015



Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Prognosis after non-invasive ventiltation (NIV) for chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure
Year: 2011

Impact of anemia in patients admitted due to a chronic obstructive pulmonary disease (COPD) exacerbation.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Bacterial infection-a common cause of acute exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 576s
Year: 2006

The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP)
Source: International Congress 2014 – Clinical presentations
Year: 2014


Use of antibiotics in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009

Can chronic obstructive lung disease (COPD) criteria be used to manage bronchiectasis (BR) and obliterative bronchiolitis (OB) in children surviving severe lung infection?
Source: Eur Respir J 2001; 18: Suppl. 33, 172s
Year: 2001

Genomic variability of haemophilus in patients with COPD
Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients
Year: 2006